Neurocrine Biosciences Inc (NBIX)
138.97
-1.12
(-0.80%)
USD |
NASDAQ |
Apr 24, 16:00
139.00
+0.03
(+0.02%)
After-Hours: 20:00
Neurocrine Biosciences Price: 138.97 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 140.89 | 144.70 | 138.01 | 138.97 | 881991.0 |
| Apr 23, 2024 | 141.00 | 145.00 | 139.22 | 140.09 | 1.608M |
| Apr 22, 2024 | 132.48 | 134.18 | 131.79 | 133.66 | 575067.0 |
| Apr 19, 2024 | 132.65 | 133.65 | 130.13 | 132.00 | 556303.0 |
| Apr 18, 2024 | 133.23 | 134.20 | 131.00 | 132.54 | 586541.0 |
| Apr 17, 2024 | 133.11 | 134.44 | 131.36 | 133.23 | 571093.0 |
| Apr 16, 2024 | 131.78 | 135.18 | 131.49 | 132.99 | 1.033M |
| Apr 15, 2024 | 134.97 | 137.00 | 131.52 | 131.74 | 767245.0 |
| Apr 12, 2024 | 136.22 | 137.78 | 134.63 | 134.66 | 577344.0 |
| Apr 11, 2024 | 138.03 | 138.67 | 135.28 | 135.93 | 809142.0 |
| Apr 10, 2024 | 138.45 | 140.54 | 137.09 | 138.09 | 639131.0 |
| Apr 09, 2024 | 140.07 | 141.45 | 138.00 | 138.94 | 598996.0 |
| Apr 08, 2024 | 138.03 | 139.68 | 137.72 | 139.44 | 615701.0 |
| Apr 05, 2024 | 137.43 | 139.75 | 136.03 | 138.92 | 458610.0 |
| Apr 04, 2024 | 138.17 | 140.43 | 136.74 | 137.61 | 1.015M |
| Apr 03, 2024 | 137.72 | 140.18 | 137.36 | 137.59 | 614144.0 |
| Apr 02, 2024 | 140.61 | 140.61 | 136.12 | 137.74 | 913872.0 |
| Apr 01, 2024 | 137.30 | 141.75 | 136.84 | 141.38 | 995785.0 |
| Mar 28, 2024 | 137.83 | 138.72 | 135.97 | 137.92 | 1.246M |
| Mar 27, 2024 | 141.38 | 141.73 | 133.42 | 137.83 | 1.174M |
| Mar 26, 2024 | 141.43 | 142.31 | 139.94 | 141.16 | 594739.0 |
| Mar 25, 2024 | 141.50 | 142.08 | 138.85 | 140.25 | 535108.0 |
| Mar 22, 2024 | 145.31 | 145.42 | 137.35 | 141.43 | 938631.0 |
| Mar 21, 2024 | 140.05 | 148.37 | 139.31 | 143.74 | 2.512M |
| Mar 20, 2024 | 140.75 | 141.65 | 137.14 | 140.65 | 653043.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
72.24
Minimum
Apr 30 2019
143.74
Maximum
Mar 21 2024
102.78
Average
99.37
Median
Sep 23 2020
Price Benchmarks
| Globus Medical Inc | 51.44 |
| Inspire Medical Systems Inc | 234.19 |
| AIM ImmunoTech Inc | 0.43 |
| Protalix BioTherapeutics Inc | 1.21 |
| Armata Pharmaceuticals Inc | 2.50 |
Price Related Metrics
| PE Ratio | 57.43 |
| PS Ratio | 7.375 |
| PEG Ratio | 0.9872 |
| Price to Book Value | 6.196 |
| Price to Free Cash Flow | 38.49 |
| Earnings Yield | 1.74% |
| Market Cap | 13.83B |
| PEGY Ratio | 0.9872 |
| Operating PE Ratio | 35.25 |
| Normalized PE Ratio | 48.63 |